These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 37086484)
1. The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms. Liu M; Li N; Tang H; Chen L; Liu X; Wang Y; Lin Y; Luo Y; Wei S; Wen W; Chen M; Wang J; Zhang N; Chen J Oncologist; 2023 Sep; 28(9):e723-e736. PubMed ID: 37086484 [TBL] [Abstract][Full Text] [Related]
2. Genetic alterations of GI-NECs involving three main signaling pathways. Dai Q; Zhang J; Long W; Haybaeck J; Yang Z Cancer Med; 2023 Apr; 12(7):8238-8250. PubMed ID: 36653904 [TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same Coin. Busico A; Maisonneuve P; Prinzi N; Pusceddu S; Centonze G; Garzone G; Pellegrinelli A; Giacomelli L; Mangogna A; Paolino C; Belfiore A; Kankava K; Perrone F; Tamborini E; Pruneri G; Fazio N; Milione M Neuroendocrinology; 2020; 110(7-8):616-629. PubMed ID: 31557757 [TBL] [Abstract][Full Text] [Related]
5. [Neuroendocrine neoplasms : Two families with distinct features unified in one classification (German version)]. Klöppel G Pathologe; 2019 May; 40(3):211-219. PubMed ID: 30969346 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Metastatic Patterns Among Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Nonneuroendocrine Carcinomas of Various Primary Organs. Park HK; Kwon GY J Korean Med Sci; 2023 Mar; 38(11):e85. PubMed ID: 36942393 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic role and prognostic value of tumor markers in high-grade gastro-enteropancreatic neuroendocrine neoplasms. Gao C; Fan Z; Yang J; Shi M; Li Y; Zhan H Pancreatology; 2023 Mar; 23(2):204-212. PubMed ID: 36710224 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE). Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208 [TBL] [Abstract][Full Text] [Related]
9. Epidemiological analysis of lung and mediastinal neuroendocrine neoplasms in Japan based on the national database. Matsuoka S; Koizumi T; Otsuki K; Tanaka Y; Kanda S; Ide S; Mishima S; Takeda T; Miura K; Eguchi T; Hamanaka K; Shimizu K Cancer Epidemiol; 2022 Apr; 77():102116. PubMed ID: 35144127 [TBL] [Abstract][Full Text] [Related]
10. Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma. Ooki A; Osumi H; Fukuda K; Yamaguchi K Cancer Metastasis Rev; 2023 Sep; 42(3):1021-1054. PubMed ID: 37422534 [TBL] [Abstract][Full Text] [Related]
11. Clinical and genomic analyses of neuroendocrine neoplasms of the breast. Wei Y; Ke X; Yu J; Jing Q; Bu H; Zeng X; Wei B Mod Pathol; 2022 Apr; 35(4):495-505. PubMed ID: 34728787 [TBL] [Abstract][Full Text] [Related]
14. World Health Organization grading classification for pancreatic neuroendocrine neoplasms: a comprehensive analysis from a large Chinese institution. Yang M; Zeng L; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y BMC Cancer; 2020 Sep; 20(1):906. PubMed ID: 32962649 [TBL] [Abstract][Full Text] [Related]
15. Molecular typing and mutational characterization of rectal neuroendocrine neoplasms. Duan X; Zhao M; Yin X; Mi L; Shi J; Li N; Han X; Han G; Wang J; Hou J; Yin F Cancer Med; 2023 Aug; 12(15):16207-16220. PubMed ID: 37387515 [TBL] [Abstract][Full Text] [Related]
16. Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review. Regalla DKR; Deep O; Paluri RK Chin Clin Oncol; 2023 Dec; 12(6):67. PubMed ID: 38073310 [TBL] [Abstract][Full Text] [Related]
17. Comprehensive genomic and transcriptomic characterization of high-grade gastro-entero-pancreatic neoplasms. Angerilli V; Sabella G; Simbolo M; Lagano V; Centonze G; Gentili M; Mangogna A; Coppa J; Munari G; Businello G; Borga C; Schiavi F; Pusceddu S; Leporati R; Oldani S; Fassan M; Milione M Br J Cancer; 2024 Jul; 131(1):159-170. PubMed ID: 38729995 [TBL] [Abstract][Full Text] [Related]
18. Identification of functional pathways and molecular signatures in neuroendocrine neoplasms by multi-omics analysis. Melone V; Salvati A; Palumbo D; Giurato G; Nassa G; Rizzo F; Palo L; Giordano A; Incoronato M; Vitale M; Mian C; Di Biase I; Cristiano S; Narciso V; Cantile M; Di Mauro A; Tatangelo F; Tafuto S; Modica R; Pivonello C; Salvatore M; Colao A; Weisz A; Tarallo R J Transl Med; 2022 Jul; 20(1):306. PubMed ID: 35794609 [TBL] [Abstract][Full Text] [Related]
19. A Subset of Large Cell Neuroendocrine Carcinomas in the Gastroenteropancreatic Tract May Evolve from Pre-existing Well-Differentiated Neuroendocrine Tumors. Pelosi G; Bianchi F; Dama E; Metovic J; Barella M; Sonzogni A; Albini A; Papotti M; Gong Y; Vijayvergia N Endocr Pathol; 2021 Sep; 32(3):396-407. PubMed ID: 33433886 [TBL] [Abstract][Full Text] [Related]
20. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract. Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]